US Bancorp’s MiNK Therapeutics INKT Stock Holding History
Bought
Maintained
Sold
Other funds holding INKT
BS
US Bancorp's INKT Position: Q3 2026 in Review
US Bancorp held its MiNK Therapeutics (INKT) position steady in Q3 2026 at 1,995 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #3120.
US Bancorp first reported a position in INKT in Q2 2026 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold INKT as of Q3 2026.
- US Bancorp held 1,995 shares of MiNK Therapeutics worth $25K as of Q3 2026.
- US Bancorp left its MiNK Therapeutics share count unchanged in Q3 2026.
- MiNK Therapeutics made up ﹤0.01% of US Bancorp's portfolio in Q3 2026, its #3120 holding.
- US Bancorp first reported a position in MiNK Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 26 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q3 2026.
Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.